Attach 20 - Staff Pledge Of Confidentiality

Attach 20 - Staff Pledge Of Confidentiality.doc

Resource for the Collection and Evaluation of Human Tissues and Cells from Donors with an Epidemiology Profile (NCI)

Attach 20 - Staff Pledge Of Confidentiality

OMB: 0925-0623

Document [doc]
Download: doc | pdf

Attachment 20: Staff Pledge of Confidentiality

Maryland Lung Cancer Study Page 6-1

Interviewer Manual July 2, 2007



Guidelines for Confidentiality of Study Data and Results


The Maryland Lung Cancer Study will comprise three groups of participants: (1) Hospital Based Cases with Lung Cancer; (2) Hospital Based Controls who will be frequency matched to cases by age, gender, race and smoking history; and (3) Population Based Controls who will be frequency matched to cases by age, gender, and race. The Case Control of Prostate Cancer will comprise two groups of participants: (1) Hospital Based Cases with Prostate Cancer; (2) Population Based Controls who will be frequency matched to cases by age, gender, and race. These studies, sponsored by the National Cancer Institute (NCI) currently include three Hospital Centers. All study personnel are partners in seeing that the Maryland Cancer Study is successfully carried to completion. The following guidelines clarify the responsibilities of the participating partners.


All personnel must read the Interviewer Manual and be willing to abide by the specified methods of data collection, reporting, and dissemination of findings specified therein. Individual patient data will be kept confidential at all times. The results of data analysis related to the Maryland Cancer Study will be kept confidential until such time as the relevant study findings have been reported in public. Failure to comply with these guidelines may jeopardize the study findings and the legitimate concerns of other members of the Maryland Cancer Study.


Agreement


I agree to abide by the Maryland Cancer Study methods specified in the Interviewers Manual. As a member of the Maryland Cancer Study, I agree to keep confidential individual patient data, and the results of interim and final analysis. My signature confirms that I have read the Guidelines for Confidentiality of Study Data and Results as set forth above, that I have had the opportunity to ask questions, if necessary and that I agree to abide by the Guidelines as set forth above.


__________________________________________________ ___ ___/___ ___/___ ___

Signature Mo. Day Year


__________________________________________________ ___ ___/___ ___/___ ___

Witness Mo. Day Year


File Typeapplication/msword
File TitleChapter 6:
AuthorDPerlmut
Last Modified ByVivian Horovitch-Kelley
File Modified2010-05-05
File Created2010-03-21

© 2024 OMB.report | Privacy Policy